A company that’s developing a noninvasive blood glucose monitoring system for diabetics is hoping to raise $2.5 million to boost its staff and test its device. And Columbus, Ohio-based DIRAmed said it would be willing to move out of the state if it can land new investment, CEO Will Shain said. “We are currently considering […]
A small Columbus, Ohio, company is hoping to develop a blood glucose monitor for diabetics who are sick of pricking their skin to check their sugar levels. DIRAmed LLC is one of several companies looking to cash in on what's certain to be an exploding market for products and services that help people better treat and manage diabetes and other cardiovascular diseases.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.